Moloney Securities Asset Management, LLC Abbott Laboratories Transaction History

Moloney Securities Asset Management, LLC

$714 Million
Q3 2024

A detailed history of Moloney Securities Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 19,853 shares of ABT stock, worth $2.27 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

19,853

Previous 20,590 3.58%

Holding current value

$2.27 Million

Previous $2.14 Million 5.8%

% of portfolio

0.32%

Previous 0.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$100.07 - $118.13 $73,751 - $87,061	-737 Reduced 3.58%	19,853 $2.26 Million
Q2 2024 Jul 30, 2024	SELL	$100.73 - $112.44 $252,127 - $281,437	-2,503 Reduced 10.84%	20,590 $2.14 Million
Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $39,317 - $43,424	-359 Reduced 1.53%	23,093 $2.62 Million
Q4 2023 Jan 30, 2024	SELL	$90.19 - $110.4 $39,954 - $48,907	-443 Reduced 1.85%	23,452 $2.58 Million
Q3 2023 Oct 31, 2023	BUY	$95.53 - $114.62 $78,143 - $93,759	818 Added 3.54%	23,895 $2.31 Million
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $74,577 - $83,094	740 Added 3.31%	23,077 $2.52 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $71,095 - $83,683	-734 Reduced 3.18%	22,337 $2.26 Million
Q4 2022 Jan 30, 2023	SELL	$95.06 - $111.52 $39,069 - $45,834	-411 Reduced 1.75%	23,071 $2.53 Million
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $7,644 - $8,850	-79 Reduced 0.34%	23,482 $2.27 Million
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $30,620 - $37,011	-300 Reduced 1.26%	23,561 $2.56 Million
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $65,789 - $80,226	-577 Reduced 2.36%	23,861 $2.82 Million
Q4 2021 Jan 28, 2022	SELL	$115.53 - $141.46 $255,205 - $312,485	-2,209 Reduced 8.29%	24,438 $3.44 Million
Q3 2021 Oct 27, 2021	SELL	$116.66 - $129.06 $363,979 - $402,667	-3,120 Reduced 10.48%	26,647 $3.15 Million
Q2 2021 Jul 26, 2021	SELL	$105.79 - $124.53 $225,015 - $264,875	-2,127 Reduced 6.67%	29,767 $3.45 Million
Q1 2021 Apr 28, 2021	BUY	$108.84 - $128.23 $43,971 - $51,804	404 Added 1.28%	31,894 $3.82 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $206,010 - $224,492	-1,962 Reduced 5.87%	31,490 $3.45 Million
Q3 2020 Oct 20, 2020	SELL	$91.64 - $111.29 $122,797 - $149,128	-1,340 Reduced 3.85%	33,452 $3.64 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $385,529 - $493,430	5,035 Added 16.92%	34,792 $3.18 Million
Q1 2020 May 08, 2020	SELL	$62.82 - $91.86 $13,820 - $20,209	-220 Reduced 0.73%	29,757 $2.35 Million
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $113,603 - $126,467	-1,447 Reduced 4.6%	29,977 $2.6 Million
Q3 2019 Nov 01, 2019	SELL	$81.84 - $88.74 $231,689 - $251,222	-2,831 Reduced 8.26%	31,424 $2.63 Million
Q2 2019 Jul 29, 2019	SELL	$72.88 - $85.0 $188,394 - $219,725	-2,585 Reduced 7.02%	34,255 $2.88 Million
Q1 2019 May 03, 2019	SELL	$66.22 - $80.06 $26,223 - $31,703	-396 Reduced 1.06%	36,840 $2.95 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $28,125 - $31,861	-429 Reduced 1.14%	37,236 $2.69 Million
Q3 2018 Oct 24, 2018	SELL	$60.81 - $73.36 $5,837 - $7,042	-96 Reduced 0.25%	37,665 $0
Q2 2018 Jul 26, 2018	SELL	$57.57 - $63.54 $12,435 - $13,724	-216 Reduced 0.57%	37,761 $2.3 Million
Q1 2018 Apr 25, 2018	BUY	$56.27 - $63.62 $58,970 - $66,673	1,048 Added 2.84%	37,977 $2.28 Million
Q4 2017 Jan 25, 2018	SELL	$53.68 - $57.47 $96,355 - $103,158	-1,795 Reduced 4.64%	36,929 $2.11 Million
Q3 2017 Oct 18, 2017	BUY	$48.06 - $53.64 $1.86 Million - $2.08 Million	38,724	38,724 $2.07 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.

Account

Moloney Securities Asset Management, LLC Abbott Laboratories Transaction History